Lisa Rojkjaer Viracta Therapeutics, Inc. (VIRX) insider trading activity

VIRX Quotes by TradingView

Lisa Rojkjaer is Chief Medical Officer of Viracta Therapeutics, Inc.. Currently has a direct ownership of 48,087 shares of VIRX, which is worth approximately $7,693. The most recent transaction as insider was on Feb 27, 2023, when has been sold 2,156 shares (Common Stock) at a price of $1.68 per share, resulting in proceeds of $3,622. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.1K
0% 3M change
0% 12M change
Total Value Held $7,693

Lisa Rojkjaer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2023
SELL
Open market or private sale
$3,622 $1.68 p/Share
2,156 Reduced 4.29%
48,087 Common Stock
Feb 25 2023
BUY
Exercise of conversion of derivative security
-
4,127 Added 7.59%
50,243 Common Stock
Nov 28 2022
SELL
Open market or private sale
$5,755 $2.72 p/Share
2,116 Reduced 4.39%
46,116 Common Stock
Nov 25 2022
BUY
Exercise of conversion of derivative security
-
4,127 Added 7.88%
48,232 Common Stock
Aug 26 2022
SELL
Open market or private sale
$8,782 $4.01 p/Share
2,190 Reduced 4.73%
44,105 Common Stock
Aug 25 2022
BUY
Exercise of conversion of derivative security
-
4,127 Added 8.18%
46,295 Common Stock
May 26 2022
SELL
Open market or private sale
$4,093 $1.9 p/Share
2,154 Reduced 4.86%
42,168 Common Stock
May 25 2022
BUY
Exercise of conversion of derivative security
-
4,127 Added 8.52%
44,322 Common Stock
Feb 28 2022
SELL
Open market or private sale
$6,658 $2.78 p/Share
2,395 Reduced 5.62%
40,195 Common Stock
Feb 25 2022
BUY
Exercise of conversion of derivative security
-
4,127 Added 8.83%
42,590 Common Stock
Nov 29 2021
SELL
Open market or private sale
$12,489 $4.82 p/Share
2,591 Reduced 6.31%
38,463 Common Stock
Nov 26 2021
SELL
Open market or private sale
$9,360 $4.8 p/Share
1,950 Reduced 4.53%
41,054 Common Stock
Nov 25 2021
BUY
Exercise of conversion of derivative security
-
8,254 Added 16.1%
43,004 Common Stock
May 11 2021
BUY
Exercise of conversion of derivative security
$84,095 $2.42 p/Share
34,750 Added 50.0%
34,750 Common Stock

Also insider at

RIGL
RIGEL PHARMACEUTICALS INC Healthcare
EVP, Chief Medical Officer
LR

Lisa Rojkjaer

Chief Medical Officer
Cardiff, CA

Track Institutional and Insider Activities on VIRX

Follow Viracta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIRX shares.

Notify only if

Insider Trading

Get notified when an Viracta Therapeutics, Inc. insider buys or sells VIRX shares.

Notify only if

News

Receive news related to Viracta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIRX